Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. CNC
CNC logo

CNC Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Centene Corp (CNC) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Buy
Latest Price
61.020
1 Day change
0.63%
52 Week Range
66.550
Analysis Updated At
2026/06/19
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Centene Corp (CNC) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock has positive analyst sentiment, recent congressional purchases, and a stable technical setup with bullish moving averages. Despite some negative catalysts, the long-term growth potential and favorable analyst price targets make it a strong candidate for investment.

Technical Analysis

The stock's MACD is negative and expanding (-0.786), indicating bearish momentum. RSI is neutral at 40.797, suggesting no overbought or oversold conditions. However, moving averages are bullish (SMA_5 > SMA_20 > SMA_200), and the stock is trading near its key support level (S1: 60.746), which could provide a solid entry point.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
4
Buy
6

Positive Catalysts

  • Positive analyst sentiment with multiple price target upgrades, including a high target of $

  • Congressional purchase of $0.8M, indicating confidence in the stock.

  • Recent initiatives like the MHS Workforce Support Program and affordable housing projects demonstrate the company's commitment to social impact and long-term growth.

Neutral/Negative Catalysts

  • Employee buyout program due to revenue losses from declining Obamacare membership, with a 6% decrease in health plan members year-over-year.

  • MACD indicates bearish momentum, and the stock has an 80% chance of a slight decline (-2.09%) in the next day.

Financial Performance

Financial data is unavailable for the latest quarter, but analysts indicate favorable Q1 medical cost trends and muted cost trends in Q2, suggesting stability in the company's financials.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts are largely bullish on Centene, with multiple Buy ratings and price target upgrades. Key highlights include Deutsche Bank's upgrade to Buy with an $80 target and Barclays' Overweight rating with a $75 target. The consensus reflects optimism about the company's margin recovery and long-term earnings potential.

Wall Street analysts forecast CNC stock price to fall
15 Analyst Rating
Wall Street analysts forecast CNC stock price to fall
5 Buy
8 Hold
2 Sell
Hold
Current: 60.640
sliders
Low
32
Averages
43.07
High
59
Current: 60.640
sliders
Low
32
Averages
43.07
High
59
Barclays
Andrew Mok
Overweight
maintain
$75
AI Analysis
2026-06-16
New
Reason
Barclays
Andrew Mok
Price Target
$75
AI Analysis
2026-06-16
New
maintain
Overweight
Reason
Barclays analyst Andrew Mok does not believe Centene's voluntary buyouts to staff are driven by negative Wakely data. However, it remains unclear whether the current announcement reflects previously planned cost actions or incremental reductions, the analyst tells investors in a research note. Barclays keeps an Overweight rating on Centene shares with a $75 price target.
BofA
Buy
maintain
$72 -> $74
2026-06-04
Reason
BofA
Price Target
$72 -> $74
2026-06-04
maintain
Buy
Reason
BofA raised the firm's price target on Centene to $74 from $72 and keeps a Buy rating on the shares. Data points continue to trickle in pointing to cost trend remaining muted in Q2, says the analyst, who adds that it is "becoming more and more difficult to believe that the strong Q1 was purely a function of weak flu and storm disruption." The firm, which is "getting more bullish on MCOs," is raising price targets for several of its covered managed care organizations and upgraded UnitedHealth (UNH) to Buy.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for CNC
Unlock Now

People Also Watch